234 related articles for article (PubMed ID: 32043442)
1. The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.
Richards FO; Eigege A; Umaru J; Kahansim B; Adelamo S; Kadimbo J; Danboyi J; Mafuyai H; Saka Y; Noland GS; Anyaike C; Igbe M; Rakers L; Griswold E; Unnasch TR; Nwoke BEB; Miri E
Am J Trop Med Hyg; 2020 Mar; 102(3):582-592. PubMed ID: 32043442
[TBL] [Abstract][Full Text] [Related]
2. Status of Onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision.
Evans DS; Alphonsus K; Umaru J; Eigege A; Miri E; Mafuyai H; Gonzales-Peralta C; Adamani W; Pede E; Umbugadu C; Saka Y; Okoeguale B; Richards FO
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3113. PubMed ID: 25233351
[TBL] [Abstract][Full Text] [Related]
3. Two Nigerian States (Plateau and Nasarawa) Have Eliminated Transmission of Human Onchocerciasis-A Report of Post-Ivermectin Mass Drug Administration Surveillance.
Miri ES; Eigege A; Kahansim B; Nwodu K; Sambo Y; Mancha B; Adelamo S; Umaru J; Kadimbo J; Danboyi J; Mafuyai H; Makata E; Akpan N; Akilah J; Igbe M; Coalson J; Rakers L; Griswold E; Unnasch TR; Nwoke BEB; Noland GS; Richards FO
Am J Trop Med Hyg; 2023 Jan; 108(1):37-40. PubMed ID: 36450227
[TBL] [Abstract][Full Text] [Related]
4. Criteria to Stop Mass Drug Administration for Lymphatic Filariasis Have Been Achieved Throughout Plateau and Nasarawa States, Nigeria.
Eigege A; Evans DS; Noland GS; Davies E; Umaru J; Adelamo SE; Mancha B; King JD; Miri ES; Okoeguale B; Griswold EP; Richards FO
Am J Trop Med Hyg; 2017 Sep; 97(3):677-680. PubMed ID: 28749759
[TBL] [Abstract][Full Text] [Related]
5. Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
Dolo H; Coulibaly ME; Sow M; Coulibaly YI; Doumbia M; Sangare M; Sanogo A; Dembele B; Guindo B; Coulibaly M; Keita M; Soumaoro L; Diarra D; Dicko B; Hamill L; Doumbia S; Sangho H; Sangare Y; Zhang Y; Tallant J; Yaro AS; Mackenzie C; Nutman TB; Boakye D
PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011632. PubMed ID: 37967137
[TBL] [Abstract][Full Text] [Related]
6. The interruption of transmission of onchocerciasis in Kaduna, Kebbi and Zamfara states, Nigeria: another milestone achievement.
Isiyaku S; Igbe M; Madaki S; Hamill LC; Ndongmo P; Adamani W; Bush S; Shu'aibu J; Elhassan E; Saka Y; Anyaike C; Akpan NM; Joel A; Nyior A; Abdullahi A; Aleiro A; Labbo A; Mafuyai HB; Nwoke BEB
Int Health; 2022 Sep; 14(Suppl 2):ii43-ii54. PubMed ID: 36130252
[TBL] [Abstract][Full Text] [Related]
7. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
Wilson NO; Badara Ly A; Cama VA; Cantey PT; Cohn D; Diawara L; Direny A; Fall M; Feeser KR; Fox LM; Kabore A; Seck AF; Sy N; Ndiaye D; Dubray C
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005198. PubMed ID: 27926918
[TBL] [Abstract][Full Text] [Related]
9. Integrated transmission assessment surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria.
Anagbogu IN; Saka YA; Surakat OA; Okoronkwo C; Davies E; Oyale P; Ekpo UF; Amazigo UV; Barbre K; Igbe M; Nyior A; Jacob SM; Gideon Nteun U; Abubakar Umar Z
Parasit Vectors; 2022 Jun; 15(1):201. PubMed ID: 35698164
[TBL] [Abstract][Full Text] [Related]
10. Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.
Komlan K; Vossberg PS; Gantin RG; Solim T; Korbmacher F; Banla M; Padjoudoum K; Karabou P; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006312. PubMed ID: 29494606
[TBL] [Abstract][Full Text] [Related]
11. Post-Treatment Surveillance for Lymphatic Filariasis in Plateau and Nasarawa States, Nigeria: Results of Transmission Assessment Surveys.
Eigege A; Noland GS; Adelamo SE; Nwodu K; Sallau A; Umaru J; Mancha BS; Davies E; Danboyi J; Kadimbo JA; Saka YA; Anagbogu I; Miri ES; Richards FO
Am J Trop Med Hyg; 2020 Jun; 102(6):1404-1410. PubMed ID: 32228796
[TBL] [Abstract][Full Text] [Related]
12. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
[TBL] [Abstract][Full Text] [Related]
13. The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa.
Katabarwa MN; Zarroug IMA; Negussu N; Aziz NM; Tadesse Z; Elmubark WA; Shumo Z; Meribo K; Kamal H; Mohammed A; Bitew Y; Seid T; Bekele F; Yilak A; Endeshaw T; Hassen M; Tillahun A; Samuel F; Birhanu H; Asmare T; Boakye D; Feleke SM; Unnasch T; Post R; Higazi T; Griswold E; Mackenzie C; Richards F
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007830. PubMed ID: 32027648
[TBL] [Abstract][Full Text] [Related]
14. Assessing Hypoendemic Onchocerciasis in
Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
[TBL] [Abstract][Full Text] [Related]
15. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
[TBL] [Abstract][Full Text] [Related]
16. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
17. Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern Liberia.
Eneanya OA; Gankpala L; Goss CW; Momolu AT; Nyan ES; Gray EB; Fischer K; Curtis K; Bolay FK; Weil GJ; Fischer PU
Acta Trop; 2022 Jul; 231():106437. PubMed ID: 35405102
[TBL] [Abstract][Full Text] [Related]
18. Integration of mass drug administration programmes in Nigeria: The challenge of schistosomiasis.
Richards FO; Eigege A; Miri ES; Jinadu MY; Hopkins DR
Bull World Health Organ; 2006 Aug; 84(8):673-6. PubMed ID: 16917658
[TBL] [Abstract][Full Text] [Related]
19. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
20. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
